| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.007 | 0.9 |